Chemotherapy-induced peripheral neuropathy (CIPN) is not only a bothersome symptom for patients being treated for cancer, but it also can significantly impact patients' daily lives, according to Grace Campbell, PhD, MSW, RN, CNL, CRRN, an assistant professor at the University of Pittsburgh School of Nursing. 

Campbell discussed a recent pilot study of women with gynecologic cancer who were assessed before, during, and after chemotherapy treatment. Those who had an early onset of CIPN were more likely to report significant neuropathy that interfered with their daily lives by the end of their treatment.

Videos

Chemotherapy-induced periphreal neuropathy can affect patients' daily living, and some individuals may be more prone to it than others.

Grace Campbell, PhD, MSW, RN, CNL, CRRN

Articles

Examining CIPN's Effects on Daily Lives